CMPX Compass Therapeutics, Inc. - Common Stock
CMPX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
CMPX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
CMPX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 9 42,9%
- Achat 10 47,6%
- Conserver 2 9,5%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
12 analystes · 2026-08-13Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.13 | $-0.11 | -0.02% |
| 31 mars 2026 | $-0.10 | $-0.10 | 0.00% |
| 31 décembre 2025 | $-0.09 | $-0.09 | 0.00% |
| 30 septembre 2025 | $-0.08 | $-0.14 | 0.06% |
| 30 juin 2025 | $-0.14 | $-0.12 | -0.02% |
| 31 mars 2025 | $-0.12 | $-0.11 | -0.01% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CMPX | $958M | — | — | — | -45.9% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $850.0K | $0 | |
| R&D Expense | $56M | $42M | $38M | |
| SG&A Expense | $17M | $15M | $12M | |
| Operating Expenses | $73M | $57M | $50M | |
| Operating Income | $-73M | $-57M | $-50M | |
| Interest Income | $6M | $7M | $8M | |
| Other Non-op | $6M | $7M | $8M | |
| Pretax Income | · | · | $-42M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-66M | $-49M | $-42M | |
| EPS (Basic) | $-0.42 | $-0.36 | $-0.33 | |
| Shares (Basic) | 157,695,000 | 137,384,000 | 127,027,000 | |
| Shares (Diluted) | · | 137,400,000 | · | |
| EBITDA | $-73M | $-57M | $-50M |
Bilan 20
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $31M | $43M | $24M | |
| Short-term Investments | $178M | $83M | $128M | |
| Prepaid Expense | $913.0K | $6M | $1M | |
| Current Assets | $210M | $133M | $154M | |
| PP&E (Net) | $102.0K | $353.0K | $898.0K | |
| PP&E (Gross) | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $6M | $6M | |
| Other Non-current Assets | · | $568.0K | $320.0K | |
| Total Assets | $220M | $140M | $157M | |
| Accounts Payable | $2M | $2M | $4M | |
| Accrued Liabilities | $11M | $6M | $3M | |
| Current Liabilities | $14M | $9M | $8M | |
| Capital Leases | $9M | $6M | $536.0K | |
| Total Liabilities | $23M | $15M | $8M | |
| Common Stock | $18.0K | $14.0K | $13.0K | |
| Retained Earnings | $-431M | $-365M | $-315M | |
| AOCI | $280.0K | $210.0K | $37.0K | |
| Stockholders' Equity | $197M | $125M | $149M | |
| Liabilities + Equity | $220M | $140M | $157M | |
| Shares Outstanding | 178,324,000 | 137,820,000 | 127,668,000 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $276.0K | $589.0K | $699.0K | |
| Stock-based Comp | $8M | $9M | $6M | |
| Operating Cash Flow | $-49M | $-45M | $-41M | |
| CapEx | $25.0K | $44.0K | $30.0K | |
| Investing Cash Flow | $-93M | $47M | $27M | |
| Stock Issued | $138M | $18M | $3M | |
| Net Stock Activity | $138M | $18M | $3M | |
| Financing Cash Flow | $130M | $17M | $3M | |
| Net Change in Cash | $-13M | $19M | $-11M | |
| Free Cash Flow | $-49M | $-45M | $-41M |
Rentabilité 6
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -6661.8% | · | |
| Net Margin | · | -5808.8% | · | |
| EBITDA Margin | · | -6661.8% | · | |
| ROA | -36.9% | -33.2% | -23.8% | |
| ROE | -45.9% | -37.5% | -27.5% | |
| ROIC | · | · | -33.9% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 15.0 | 15.0 | 19.7 | |
| Quick Ratio | 15.0 | 14.3 | 19.5 |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Valorisation (TTM) 8
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $850.0K | $0 | |
| Net Income TTM | $-66M | $-49M | $-42M | |
| Market Cap | $958M | $200M | $199M | |
| P/S | · | 235.1 | · | |
| P/B | 4.9 | 1.6 | 1.3 | |
| P / Tangible Book | 4.9 | 1.6 | 1.3 | |
| P / Cash Flow | -19.5 | -4.5 | -4.9 | |
| P / FCF | -19.5 | -4.5 | -4.9 |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $850.0K | · | $0 | $0 | $0 | |
| R&D Expense | · | $13M | $14M | $13M | $16M | $13M | $13M | $9M | $11M | $10M | · | · | · | |
| SG&A Expense | $7M | $7M | $4M | $3M | $5M | $5M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $27M | $20M | $18M | $16M | $21M | $18M | $17M | $12M | $16M | $13M | $15M | $12M | $13M | |
| Operating Income | $-27M | $-20M | $-18M | $-16M | $-21M | $-18M | $-17M | $-12M | $-15M | $-13M | $-15M | $-12M | $-13M | |
| Interest Income | · | · | · | · | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Pretax Income | · | · | · | · | · | $-17M | · | · | $-13M | $-11M | · | $-10M | $-11M | |
| Income Tax | · | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-25M | $-18M | $-16M | $-14M | $-20M | $-17M | $-15M | $-10M | $-13M | $-11M | $-13M | $-10M | $-11M | |
| EPS (Basic) | $-0.13 | $-0.10 | $-0.08 | $-0.08 | $-0.14 | $-0.12 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.09 | |
| Shares (Basic) | 186,798,000 | 186,400,000 | -287,605,000 | 168,782,000 | 138,282,000 | 138,236,000 | -274,402,000 | 137,589,000 | 137,589,000 | 136,608,000 | -253,501,000 | 127,424,000 | 126,729,000 | |
| Shares (Diluted) | · | · | · | · | · | 138,200,000 | 100,000 | 137,600,000 | · | · | · | · | · | |
| EBITDA | $-27M | $-20M | · | $-16M | $-21M | $-18M | · | $-12M | $-15M | $-13M | · | $-12M | $-13M |
Bilan 20
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $55M | $31M | $46M | $23M | $41M | $43M | $37M | $19M | $24M | $24M | $30M | $19M | |
| Short-term Investments | $144M | $140M | $178M | $174M | $78M | $72M | $83M | $99M | $127M | $133M | $128M | $133M | $149M | |
| Prepaid Expense | $1M | $1M | $913.0K | $1M | $5M | $12M | $6M | $6M | $7M | $2M | $1M | $3M | $7M | |
| Current Assets | $181M | $196M | $210M | $221M | $106M | $124M | $133M | $141M | $154M | $159M | $154M | $167M | $175M | |
| PP&E (Net) | $324.0K | $169.0K | $102.0K | $119.0K | $131.0K | $231.0K | $353.0K | $493.0K | $592.0K | $744.0K | $898.0K | $1M | $1M | |
| PP&E (Gross) | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $568.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | |
| Total Assets | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Accounts Payable | $3M | $906.0K | $2M | $3M | $3M | $2M | $2M | $960.0K | $1M | $854.0K | $4M | $2M | $724.0K | |
| Accrued Liabilities | $12M | $8M | $11M | $9M | $11M | $13M | $6M | $3M | $7M | $2M | $3M | $6M | $8M | |
| Current Liabilities | $16M | $10M | $14M | $12M | $14M | $15M | $9M | $4M | $10M | $4M | $8M | $9M | $10M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $6M | $6M | $6M | $0 | $189.0K | $536.0K | $869.0K | $1M | |
| Total Liabilities | $24M | $19M | $23M | $22M | $23M | $21M | $15M | $11M | $10M | $4M | $8M | $10M | $11M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $53.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | |
| Retained Earnings | $-475M | $-449M | $-431M | $-415M | $-401M | $-381M | $-365M | $-350M | $-339M | $-326M | $-315M | $-302M | $-292M | |
| AOCI | $-251.0K | $-159.0K | $280.0K | $274.0K | $208.0K | $190.0K | $210.0K | $486.0K | $-91.0K | $-90.0K | $37.0K | $-430.0K | $-507.0K | |
| Stockholders' Equity | $166M | $186M | $197M | $210M | $93M | $110M | $125M | $138M | $146M | $157M | $149M | $160M | $168M | |
| Liabilities + Equity | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Shares Outstanding | 180,088,000 | 180,088,000 | 178,324,000 | 177,572,000 | 138,282,000 | 138,282,000 | 137,820,000 | 137,589,000 | 137,589,000 | 137,589,000 | 127,668,000 | 127,445,000 | 127,388,000 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21.0K | $15.0K | $17.0K | $19.0K | $100.0K | $140.0K | $140.0K | $143.0K | $152.0K | $154.0K | $161.0K | $164.0K | $180.0K | |
| Stock-based Comp | $5M | $5M | $2M | $1M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-15M | $-17M | $-13M | $-11M | $-12M | $-13M | $-9M | $-11M | $-11M | $-14M | $-12M | $-6M | $-10M | |
| CapEx | $176.0K | $82.0K | $0 | $7.0K | $0 | $18.0K | $0 | $44.0K | $0 | $0 | $9.0K | $10.0K | $11.0K | |
| Investing Cash Flow | $-5M | $38M | $-3M | $-95M | $-6M | $12M | $15M | $29M | $6M | $-4M | $6M | $17M | $-667.0K | |
| Stock Issued | · | · | $0 | $138M | $0 | $0 | $0 | $0 | $0 | $18M | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $18M | · | · | · | |
| Financing Cash Flow | $0 | $3M | $1M | $129M | $0 | $-815.0K | $-94.0K | $-2.0K | $1.0K | $17M | $-158.0K | $21.0K | $3M | |
| Net Change in Cash | $-20M | $25M | $-16M | $23M | $-18M | $-2M | $6M | $18M | $-4M | $-554.0K | $-6M | $11M | $-8M | |
| Free Cash Flow | · | $-17M | · | · | · | $-13M | · | · | · | · | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| ROA | -16.4% | -10.9% | · | -7.5% | -14.6% | -11.4% | · | -6.6% | -7.8% | -6.2% | · | -6.7% | -7.1% | |
| ROE | -19.4% | -12.3% | · | -8.2% | -16.6% | -12.4% | · | -7.0% | -8.3% | -6.5% | · | -7.2% | -7.6% | |
| ROIC | · | · | · | · | · | -16.3% | · | · | -10.3% | -8.1% | · | -7.4% | -7.9% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.2 | 19.0 | · | 17.8 | 7.7 | 8.3 | · | 31.8 | 16.2 | 40.7 | · | 18.3 | 18.1 | |
| Quick Ratio | 11.2 | 18.9 | · | 17.7 | 7.3 | 7.6 | · | 30.5 | 15.4 | 40.1 | · | 17.9 | 17.4 |
Efficacité 1
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | · | · |
Valorisation (TTM) 6
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-69M | · | $-61M | $-60M | $-51M | · | $-44M | $-45M | $-40M | · | $-41M | $-40M | |
| Market Cap | $394M | $953M | · | $622M | $360M | $263M | · | $253M | $138M | $272M | · | $251M | $405M | |
| P/B | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Tangible Book | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Cash Flow | · | -55.2 | · | · | · | -19.9 | · | · | · | -19.6 | · | · | · | |
| P / FCF | · | -54.9 | · | · | · | -19.9 | · | · | · | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $0 | $850.0K | $0 | — | — |
| Marge d'exploitation % | — | -6661.8% | — | — | — |
| Résultat net | $-66M | $-49M | $-42M | $-39M | $-82M |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | — | — | — | — | 0.0 |
| Ratio de liquidité | 15.0 | 15.0 | 19.7 | 12.0 | 13.8 |
| Ratio de liquidité réduite | 15.0 | 14.3 | 19.5 | 11.5 | 13.6 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-49M | $-45M | $-41M | $-34M | $-21M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 227 déclarants · $346.6M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 72 (+16 vs T. préc.) | 43 (+24 vs T. préc.) | 76 (+10 vs T. préc.) | 45 (-2 vs T. préc.) | -13.8M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $39 399 813 | 17 990 782 | 11,37% | Actions |
| VANGUARD GROUP INC | $37 441 444 | 6 972 336 | 10,80% | Actions |
| ORBIMED ADVISORS LLC | $33 331 787 | 15 219 994 | 9,62% | Actions |
| MONTANOVA CAPITAL, LLC | $30 881 538 | 14 101 159 | 8,91% | Actions |
| STATE STREET CORP | $21 798 500 | 9 953 653 | 6,29% | Actions |
| ENAVATE SCIENCES GP, LLC | $17 056 049 | 7 788 150 | 4,92% | Actions |
| Vivo Capital, LLC | $16 987 961 | 7 757 060 | 4,90% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $13 400 133 | 6 118 782 | 3,87% | Actions |
| Palo Alto Investors LP | $12 771 670 | 5 831 813 | 3,68% | Actions |
| MILLENNIUM MANAGEMENT LLC | $10 322 011 | 4 713 247 | 2,98% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 258 560 | 3 771 032 | 2,38% | Actions |
| Qube Research & Technologies Ltd | $8 075 601 | 3 687 489 | 2,33% | Actions |
| Blue Owl Capital Holdings LP | $7 936 726 | 3 624 076 | 2,29% | Actions |
| Rock Springs Capital Management LP | $7 719 595 | 3 524 929 | 2,23% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $7 167 845 | 3 271 990 | 2,07% | Actions |
| GOLDMAN SACHS GROUP INC | $5 881 777 | 2 685 743 | 1,70% | Actions |
| Birchview Capital, LP | $3 668 250 | 1 675 000 | 1,06% | Actions |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $3 066 000 | 1 400 000 | 0,88% | Actions |
| Fisher Asset Management, LLC | $3 048 238 | 1 391 890 | 0,88% | Actions |
| ROYCE & ASSOCIATES LP | $2 927 548 | 1 336 780 | 0,84% | Actions |
| FMR LLC | $2 654 709 | 1 212 196 | 0,77% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2 598 435 | 1 186 500 | 0,75% | Actions |
| Atle Fund Management AB | $2 296 418 | 1 048 593 | 0,66% | Actions |
| Squarepoint Ops LLC | $2 206 440 | 1 007 507 | 0,64% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $2 192 054 | 1 000 938 | 0,63% | Actions |
| Blackstone Inc. | $1 970 860 | 899 936 | 0,57% | Actions |
| FIRST TRUST ADVISORS LP | $1 767 338 | 807 004 | 0,51% | Actions |
| KVP Capital Advisors, LP | $1 688 490 | 771 000 | 0,49% | Actions |
| UBS Group AG | $1 560 951 | 712 763 | 0,45% | Actions |
| CITIGROUP INC | $1 546 887 | 706 341 | 0,45% | Actions |
| Burkehill Global Management, LP | $1 533 000 | 700 000 | 0,44% | Actions |
| JPMORGAN CHASE & CO | $1 505 377 | 696 934 | 0,43% | Actions |
| Point72 Asset Management, L.P. | $1 503 604 | 686 577 | 0,43% | Actions |
| ACUTA CAPITAL PARTNERS, LLC | $1 303 516 | 595 213 | 0,38% | Actions |
| CM Management, LLC | $1 204 500 | 550 000 | 0,35% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $1 147 072 | 523 777 | 0,33% | Actions |
| MORGAN STANLEY | $1 088 441 | 497 005 | 0,31% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $1 045 092 | 477 211 | 0,30% | Actions |
| BANK OF AMERICA CORP /DE/ | $994 089 | 453 922 | 0,29% | Actions |
| ALLIANCEBERNSTEIN L.P. | $856 345 | 161 880 | 0,25% | Actions |
| Artia Global Partners LP | $839 208 | 383 200 | 0,24% | Actions |
| ArrowMark Colorado Holdings LLC | $798 785 | 364 742 | 0,23% | Actions |
| TWO SIGMA INVESTMENTS, LP | $701 483 | 320 312 | 0,20% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $675 166 | 308 295 | 0,19% | Actions |
| ALGERT GLOBAL LLC | $674 761 | 308 110 | 0,19% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $663 874 | 303 139 | 0,19% | Actions |
| NATIXIS | $651 996 | 297 715 | 0,19% | Actions |
| Exome Asset Management LLC | $604 801 | 276 165 | 0,17% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $594 152 | 112 316 | 0,17% | Actions |
| Caption Management, LLC | $577 234 | 263 577 | 0,17% | Actions |
| TEMA ETFS LLC | $537 945 | 100 176 | 0,16% | Actions |
| Seven Fleet Capital Management LP | $510 415 | 233 066 | 0,15% | Actions |
| DV EQUITIES, LLC | $510 415 | 233 066 | 0,15% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $486 572 | 222 179 | 0,14% | Actions |
| XTX Topco Ltd | $476 292 | 217 485 | 0,14% | Actions |
| Orion Porfolio Solutions, LLC | $468 360 | 213 863 | 0,14% | Actions |
| Optimize Financial Inc | $425 522 | 80 439 | 0,12% | Actions |
| Rafferty Asset Management, LLC | $416 376 | 190 126 | 0,12% | Actions |
| ALPS ADVISORS INC | $400 282 | 182 777 | 0,12% | Actions |
| Mariner, LLC | $378 432 | 172 821 | 0,11% | Actions |
| Swiss National Bank | $376 023 | 171 700 | 0,11% | Actions |
| JANE STREET GROUP, LLC | $372 300 | 170 000 | 0,11% | Option d'achat |
| Virtus Investment Advisers, LLC | $352 986 | 161 181 | 0,10% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $352 371 | 160 900 | 0,10% | Actions |
| RHUMBLINE ADVISERS | $346 984 | 158 444 | 0,10% | Actions |
| JANUS HENDERSON GROUP PLC | $293 846 | 55 600 | 0,08% | Actions |
| IEQ CAPITAL, LLC | $269 256 | 122 948 | 0,08% | Actions |
| ADAR1 Capital Management, LLC | $267 469 | 122 132 | 0,08% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $249 165 | 113 774 | 0,07% | Actions |
| Bank of New York Mellon Corp | $242 878 | 110 903 | 0,07% | Actions |
| WELLS FARGO & COMPANY/MN | $240 447 | 109 793 | 0,07% | Actions |
| Quadrature Capital Ltd | $237 068 | 108 250 | 0,07% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $233 388 | 106 570 | 0,07% | Actions |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $230 198 | 105 113 | 0,07% | Actions |
| PROFUND ADVISORS LLC | $208 508 | 95 209 | 0,06% | Actions |
| Schonfeld Strategic Advisors LLC | $201 975 | 92 227 | 0,06% | Actions |
| TUDOR INVESTMENT CORP ET AL | $197 196 | 90 044 | 0,06% | Actions |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $194 711 | 83 567 | 0,06% | Actions |
| Jain Global LLC | $193 381 | 88 302 | 0,06% | Actions |
| SmartHarvest Portfolios, LLC | $189 453 | 86 508 | 0,05% | Actions |
| GROUP ONE TRADING LLC | $178 610 | 81 557 | 0,05% | Actions |
| BlackRock, Inc. | $178 213 | 81 376 | 0,05% | Actions |
| CITADEL ADVISORS LLC | $177 390 | 81 000 | 0,05% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $163 569 | 74 689 | 0,05% | Actions |
| CITADEL ADVISORS LLC | $161 622 | 73 800 | 0,05% | Option d'achat |
| MetLife Investment Management, LLC | $156 412 | 71 421 | 0,05% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $149 395 | 68 217 | 0,04% | Actions |
| ExodusPoint Capital Management, LP | $147 777 | 67 478 | 0,04% | Actions |
| CITADEL ADVISORS LLC | $143 445 | 65 500 | 0,04% | Option de vente |
| D. E. Shaw & Co., Inc. | $141 612 | 64 663 | 0,04% | Actions |
| Vanguard Global Advisers, LLC | $133 936 | 61 158 | 0,04% | Actions |
| Wealthcare Advisory Partners LLC | $133 507 | 60 962 | 0,04% | Actions |
| Quantbot Technologies LP | $133 209 | 60 826 | 0,04% | Actions |
| JANE STREET GROUP, LLC | $131 301 | 59 955 | 0,04% | Actions |
| SIMPLEX TRADING, LLC | $126 560 | 57 790 | 0,04% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $123 078 | 56 200 | 0,04% | Option de vente |
| Focus Partners Wealth | $116 335 | 53 121 | 0,03% | Actions |
| Invesco Ltd. | $114 701 | 52 375 | 0,03% | Actions |
| Sequoia Financial Advisors, LLC | $98 507 | 44 980 | 0,03% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $96 172 | 43 914 | 0,03% | Actions |
Initiés de la société 18 initiés · 8 dirigeants · 12 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Thomas J. Schuetz | CHIEF EXECUTIVE OFFICER | 8 février 2026 F | 6 603 336 | 0 | 0 | $0 |
| Vered Bisker-Leib | CHIEF EXECUTIVE OFFICER | 8 février 2024 F | 3 124 426 | 0 | 0 | $0 |
| Barry Shin | CFO | 2 janvier 2026 A | 525 000 | 0 | 0 | $0 |
| Jonathan Anderman | General Counsel | 29 avril 2026 P | 196 000 | 1 | 0 | $47 250 |
| Neil Lerner | Chief Accounting Officer | 29 avril 2026 P | 397 500 | 1 | 0 | $28 350 |
| Arjun Prasad | Chief Commercial Officer | 2 janvier 2026 A | — | 0 | 0 | $0 |
| Cynthia Sirard | Chief Medical Officer | 2 janvier 2026 A | — | 0 | 0 | $0 |
| Susan Kalled | Chief Scientific Officer | 18 février 2022 A | — | 0 | 0 | $0 |
| James P Boylan | Administrateur | 2 janvier 2026 A | — | 0 | 0 | $0 |
| Philip Ferneau | Administrateur | 2 janvier 2026 A | 400 280 | 0 | 0 | $0 |
| Ellen Chiniara | Administrateur | 2 janvier 2026 A | — | 0 | 0 | $0 |
| GORDON CARL L | Administrateur | 2 janvier 2026 A | 0 | 0 | 0 | $0 |
| Mary Ann Gray | Administrateur | 2 janvier 2026 A | — | 0 | 0 | $0 |
| Richard S Lindahl | Administrateur | 2 janvier 2026 A | — | 0 | 0 | $0 |
| David M Wurzer | Administrateur | 8 février 2023 A | — | 0 | 0 | $0 |
| Brett Kaplan | Administrateur | 18 février 2022 A | — | 0 | 0 | $0 |
| Stephen P Squinto | Administrateur | 18 février 2022 A | — | 0 | 0 | $0 |
| Julie Sunderland | Administrateur | 19 juin 2020 P | 2 502 025 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 5 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Commander Aggregator, LP, Enavate Sciences, LP, Enavate Sciences GP, LLC, Enavate Sciences Holdings, LLC | 18 août 2025 | 4,50% | Amendement | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×7 dépôts | 15 août 2025 | 8,90% | Amendement | — | SEC |
| Personne déclarante non divulguée | 14 novembre 2022 | — | Dépôt initial | Investissement passif | SEC |
| Philip Ferneau, Vox Health Fund, L.P., Borealis Capital Partners IV, LLC, Borealis Granite Fund, L.P., Borealis Capital Partners III, LLC | 26 juin 2020 | — | Dépôt initial | — | SEC |
| Thomas J. Schuetz | 26 juin 2020 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 30 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,27% | 185 633 NS | 31 mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,25% | 53 489 NS | 30 avril 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,07% | 441 490 NS | 30 avril 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,07% | 210 822 NS | 30 avril 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,04% | 261 767 NS | 30 avril 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 41 165 NS | 30 avril 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,01% | 46 574 NS | 31 mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 6 071 NS | 31 mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 55 815 NS | 30 avril 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 4 749 NS | 31 mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 4 800 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 51 153 NS | 30 avril 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 64 580 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 596 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 121 NS | 31 mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 28 557 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 2 437 NS | 30 avril 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 7 766 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| ITOT · iShares Trust | — | — | 22 juillet 2026 | Quotidien |
| IWV · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWN · iShares Trust | — | — | 17 août 2026 | Quotidien |
| IWM · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWC · iShares Trust | — | — | 18 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | — | — | 20 juillet 2026 | Quotidien |
| WSML · iShares Trust | — | — | 20 juillet 2026 | Quotidien |